In a liver transplant recipient with type 2 diabetes on basal-bolus insulin, adding semaglutide over eight months was followed by an HbA1c below 7%.
In plain wordsIn one liver transplant patient with type 2 diabetes, adding semaglutide to insulin was followed by better blood sugar control over eight months.
- Peptide
- Semaglutide
- Outcome
- DecreaseHbA1c after semaglutide initiation
- Study
n = 1
- Outcome group
- Glycemic control · Metabolic and weight
- Studied dose
- Dose not stated · 8 monthsAs given in this study (human).
Source sentences
Results The addition of semaglutide, over an eight-month period, assisted with glycemic control to an HbA1c of less than 7%.
1 context sentence(design, population, supporting numbers)
Practice Innovation A 63-year-old White male with a history of liver transplantation in the context of T2DM, treated with basal-bolus insulin therapy, was referred by his family medicine provider to the ambulatory care pharmacist for diabetes management because of a hemoglobin A1c (HbA1c) level greater than 10%.